ImportantCompany Update

The company has allotted 7,53,334 new equity shares to a non-promoter warrant holder upon conversion.

Venmax Drugs and Pharmaceuticals Ltd531015 · Filed with the exchange

These shares were issued at Rs. 20 each, bringing in an additional 1.13 Cr as the balance exercise price.

This boosts the company's paid-up capital to 14.48 Cr, now comprising 1.45 Cr shares.

Investors should note 7.80 lakh warrants are still pending conversion, signaling potential future equity expansion.

Read the original filing(PDF)

No comments yet. Be the first.

More from Venmax Drugs and Pharmaceuticals Ltd

All announcements